| Symbol: |
TINAGL1
|
| Description: |
tubulointerstitial nephritis antigen-like 1 [Source:HGNC Symbol;Acc:19168]
|
| Location: |
Chr1:32042116-32053288[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:141
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| TINAGL1 |
NSC 106442 |
0.048 |
Down |
| TINAGL1 |
NSC 106723 |
0.038 |
Down |
| TINAGL1 |
NSC 138333 |
0.034 |
Down |
| TINAGL1 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.049 |
Down |
| TINAGL1 |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.039 |
Down |
| TINAGL1 |
1H-Pyrazole-1-ethanol, 4,4'-azoxybis(3,5-dimethyl- |
0.028 |
Down |
| TINAGL1 |
NSC 191393 |
0.048 |
Down |
| TINAGL1 |
3-(2-PYRIDYL)-ACRYLOPHENONE |
0.037 |
Down |
| TINAGL1 |
TETRAAMMINECOPPER(2+) DITHIOCYANATE COMPOUND WITH QUINOLINE THIOCYANATE (1:3) |
0.033 |
Up |
| TINAGL1 |
NSC 201902 |
0.004 |
Down |
| TINAGL1 |
1,8-Octanediamine, N,N'-di-9-acridinyl- |
0.032 |
Down |
| TINAGL1 |
Viridomycin |
0.035 |
Down |
| TINAGL1 |
Buclizine Hydrochloride |
0.014 |
Down |
| TINAGL1 |
Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester |
0.029 |
Down |
| TINAGL1 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.03 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:7
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
| miRNA:
~ Export ~
|
Records:49
| Gene |
Gen_transcript |
miRNA |
miR_location |
| TINAGL1 |
ENST00000358947 |
hsa-mir-9-5p |
Chr1:156390184-156390206[-] |
| TINAGL1 |
ENST00000358947 |
hsa-mir-9-5p |
Chr5:87962720-87962742[-] |
| TINAGL1 |
ENST00000271064 |
hsa-mir-938 |
Chr10:29891240-29891261[-] |
| TINAGL1 |
ENST00000358947 |
hsa-mir-938 |
Chr10:29891240-29891261[-] |
|